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A B S T R A C T
Background: Subclinical (asymptomatic) cases of malaria could be a major barrier to the success of
malaria elimination programs. This study has evaluated the impact of long-lasting insecticidal nets
(LLINs) on the prevalence of subclinical malaria in the presence of pyrethroid resistance in the main
malaria vector Anopheles culicifacies on malaria transmission among a cohort of children in villages of the
Keshkal sub-district in Chhattisgarh state.
Methods: A cohort of 6582 children ages less than 14 years was enrolled from 80 study clusters. Post
monsoon survey was carried out at baseline before LLIN distribution, and 5862 children were followed up
in the subsequent year. Study outcomes included assessment of subclinical malarial infections and use of
LLINs among the study cohort in the presence of varied levels of pyrethroid resistance.
Findings: In the baseline survey, the proportion of subclinical malaria was 61%. LLIN use during the
previous night was 948%. Overall, prevalence of subclinical malaria was signiﬁcantly reduced to 1%
(p < 0001) in the second survey. LLIN users were protected from malaria (OR: 025, 95% CI = 012–052,
p < 0.001) and subclinical malaria (OR: 025, 95% CI = 011–058, p = 0001) despite the presence of
pyrethroid resistance in the study area.
Interpretation: In this low transmission area, sleeping under LLINs signiﬁcantly reduced the burden of
malaria among children. In the presence of pyrethroid resistant malaria vector, a high LLIN use of 945%
was observed to have signiﬁcantly brought down the proportion of subclinical malaria among the cohort
children.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Background
Vector control strategies including universal coverage of long-
lasting insecticidal nets (LLINs) during the last decade and a half
have signiﬁcantly contributed to overall reduction in global
malaria morbidity by 30%.1 In India, during the last decade,
malaria morbidity has been reduced by 45% from an estimated two
million reported malaria cases in year 2000 to 11 million cases in
2015 due to sustained control efforts.2 Of the remaining malaria
cases, more than 80% are contributed by tribal forested areas of ten
states including Chhattisgarh.3
Most malaria endemic countries, including India, have expand-
ed their focus from malaria control to elimination, and India has
recently launched a framework for a national level malaria
elimination programme 2016–2030. This plan envisages scaling
up of existing interventions, appropriate vector control measures,
capacity building and strengthening drug compliance among
malaria positive cases.4 At the time when the malaria control
program is focused on targeting malaria vectors through indoor
residual spraying (IRS) of insecticide and LLINs, there is a strong
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need to target malaria parasites and sub clinical carriers to
interrupt malaria transmission in endemic areas.5–7
Under the existing health care system, malaria positive cases
are captured through active and passive fever surveillance
mechanisms. Persons with conﬁrmed blood parasitemia through
either microscopy or rapid diagnostic test (RDT) receive anti-
malarial treatment. However, a sizeable proportion of the
population has been observed to harbour malaria parasites
without presentation of any symptom. Such cases are not captured
through the routine surveillance system. As carriers, they pose a
serious challenge to efforts towards malaria elimination.8,9
Several studies from malaria endemic countries have reported
that irrespective of the intensity of transmission, a large proportion
of malarial infections remain asymptomatic and contribute about
20–50% of all malaria transmission.10–13 At high levels of
gametocyte parasitemia, subclinical carriers become the parasite
reservoir14,15 and contribute to persistent transmission of malar-
ia.5,16 Subclinical infections, also known as asymptomatic or sub-
patent infections, have no standard deﬁnition, and different
studies have used their own deﬁnition with subtle differences.9
In endemic areas asymptomatic parasitemia may confer partial
immunity on repeated exposure and may provide protection
against clinical manifestations.17,18 Malaria parasitemia thus
remains asymptomatic and acts as a source for residual transmis-
sion. However, the clinical consequences of subclinical malaria are
not fully understood as they vary with different ecological,
epidemiological and environmental conditions.19
There is a dearth of Indian studies evaluating impact of LLIN use
on subclinical malarial infection and malaria transmission in
pyrethroid resistant areas. Here, we present the results of a study
on the impact of community-wide use of LLIN on the prevalence of
subclinical malaria in a cohort of children under age 14 years in the
presence of pyrethroid resistance in malaria vectors on the
protective effectiveness of LLINs.
Methods
The study was carried out during the post-monsoon seasons
(August  December) of 2014 and 2015 among a cohort of children
living in tribal forested villages in southern Chhattisgarh state, India.
Study area
Keshkal (20 5' 1 N and 81 35' 12 E), a sub-district of Kondagaon
district, has a population of about 90,000 living in 124 villages. A
basic health care facility is available through one Community
Health Centre (CHC) situated at block headquarter Keshkal, as well
as four Primary Health Centres (PHCs), each catering to a
population of about 20000–25000. Malaria transmission takes
place mainly during the rainy season (June  October). Anopheles
culicifacies is the principal vector in the region.20 For the past two
decades, synthetic pyrethroid insecticide alpha-cypermethrin
(@ 25 mg/m2 and twice a year) has been used in IRS as a major
vector control measure by the state health department in the study
area. With a consideration on year-round accessibility, 80 clusters
were selected for the study. In 2014, 31,000 LLINs were distributed
in collaboration with the state health department to cover a
population of nearly 74,000 people living in these 80 clusters. In
the remaining non-study clusters, the state health department has
distributed LLINs covering nearly 16,000 population.
Enrolment of children and baseline data collection
A cohort of 6582 children aged under 14 years was enrolled
(60–80 children/cluster) after reading out the purpose of the study
and obtaining written informed consent from the parent/guardian.
Peripheral blood smear of all cohort children was prepared for
microscopic conﬁrmation of parasitemia to assess parasite
prevalence before inclusion. Axial temperature of all study
children at the time of survey was recorded with a digital
thermometer (Dr. Diaz, Hemodiaz Life sciences Pvt. Ltd, India).
Blood smears were stained with Geimsa stain and 100 microscopic
ﬁelds of thick smear were examined at 1000 x magniﬁcation to
detect malaria parasites. Parasite density (parasites/ml blood) was
counted against 200 White Blood cells (WBCs) considering the
average of 8000 WBC/ml. All slide positive malaria cases were
treated with anti-malarial drugs according to national drug policy
[Plasmodium falciparum (Pf): artesunate + sulfadoxine  pyrimeth-
mine + primaquine; P. vivax(Pv):chloroquine + primaquine]. Follow
up slides were prepared seven days after medication to ensure
clearance of asexual parasites from the peripheral blood.
Case deﬁnition
A slide positive case (presence of asexual parasitemia) with no
symptoms of fever (axial temperature  995 F/375 C) was
considered as a case of subclinical malaria.
Active case detection
For routine fever surveillance, 30 malaria surveillance workers
were recruited from different clusters (villages) and trained in
malaria surveillance and treatment activities. To assist them in
malaria surveillance in houses of cohort children, 124 female
Community Health Volunteers i.e. mitanins, were deployed. All
cohort children were visited once in a fortnight. A follow up survey
of all cohort children was carried out after six months of
enrolment. Axial temperature was recorded using a digital
thermometer. Self-reported history of fever during the preceding
week, previous night and at the time of blood smear collection was
recorded. Information on reported use of LLINs during the previous
night was also recorded. However, in the follow up survey, 10% of
children were lost to follow up due mainly to their exiting the study
area to pursue higher studies elsewhere.
Insecticide resistance assessment
In the year 2015, wild caught full-fed An. Culicifacies adult
females caught from each cluster (100 females per test) were
exposed to deltamethrin 005% treated papers following WHO test
procedures to determine susceptibility status (WHO, 2013). Based
on median mortality the clusters were stratiﬁed into low
resistance (84% mortality) and high resistance (<84% mortality)
clusters. Thus, 3,249 and 3,333 cohort children were allocated to
low resistance and high resistance clusters respectively.
Statistical analysis
Data were entered in EpiData version 31 software. All entries
were double checked and further cleaned for error and analysed
using IBM SPSS version 20 (IBM Corp, Armonk, NY). Continuous
variables were described as mean and standard deviation (M  SD),
and categorical variables were described in percentages.
To assess the reduction in prevalence of malaria and subclinical
malaria cases in consecutive years, the data for both surveys were
combined into one data set and included ‘survey year’ as a ﬁxed
effect in the generalised estimated equation (GEE) model together
with all the other variables. Reduction in malaria from one survey
to the next, adjusted for all the other variables in the model were
analyzed.
Effect of LLIN use between cluster resistance status was
determined in a separate stratiﬁed analysis, and then overall
cross level interaction between the two was analyzed by adding
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interaction term in the GEE model to assess impact of insecticide
resistance on LLIN effectiveness.
Univariate and multivariate analyses were carried out using a
generalised estimated equation (GEE) regression model to explore
the relation between subclinical malaria and exposure variables.
GEE analysis was chosen so that within-cluster correlation can be
adjusted and possible interaction of village resistance status can be
taken into account during modelling. Response variable presence
of subclinical malaria has binary events (Yes/No). Binomial
distribution with logit link function was selected. Exchangeable
correlation structure was chosen for the model. In the model,
explanatory variables that included age group, gender, and last
night LLIN use were added and village insecticide status was taken
as main effect. Study cluster variable was taken at the subject level.
The results of GEE regression analyses were stated as unadjusted
and adjusted odds ratio (OR) with 95% conﬁdence interval (CI) and
associated P-value.
Informed consent and ethical clearance
The purpose of the study was described in the local language to
all study participants, and study related queries such as routine
surveillance and blood slide collection procedures etc. were
addressed. A written informed consent was collected from the
parents or guardians of the enrolled children. This study was
undertaken as a part of a WHO-coordinated multi-country project
and ethical clearance was obtained from the Institutional Ethics
Committee (ECR/NIMR/EC/2010/75).
Results
Demographic and clinical characteristics
Between September and November 2014, 6582 children (Male:
Female  1:103) were enrolled from 80 study clusters. The mean
age of the study cohort was 63 years (SD- 34); children of age
group 5–9 years constituted 40% of the study population followed
by 2–4 years (289%). Of all children, 114(17%) and 196 (33%)
reported with a history of fever (i.e., the previous night or at the
time of survey) in the baseline and follow up surveys respectively.
Detailed demographic and clinical description of the study
population is given in Table 1.
In the baseline survey, peripheral blood samples from a total of
490/6582 (74%) children had malarial parasites (Table 2). A total of
398 (812%) microscopy positive children presenting without any
symptoms at the time of survey had either Pf (331) or Pv (67)
parasitemia. One child had a subclinical infection with P. malariae.
In all, 91 microscopy positive children (14%) had malarial infection
(Pf = 87; Pv = 4) associated with clinical symptoms. Among Pf
infections, asexual parasitemia was higher (GMD 1680 parasites/
ml, range 40–508880) in symptomatic cases as compared to
asymptomatic cases (GMD 717 parasites/ml, range 40–46760).
Similarly, sexual (gametocyte) parasitemia in symptomatic Pf
infections was nearly two times higher than in asymptomatic
children (GMD 613 vs 303 parasite/ml).
In the follow up survey carried out during 2015, blood samples
of 5862 children were collected, of which 82 (14%) were positive
for malaria parasites. Among the positives, 46 (561%) and 19
(232%) children had subclinical Pf and Pv infections, respectively.
Comparative analysis of subclinical malaria and total malaria cases in
baseline and follow up survey
The prevalence of malaria was signiﬁcantly reduced during the
follow-up survey in August 2015 as compared to the baseline
survey in November 2014 (SPR = 74% vs 14%, p < 0001) after
adjusting other factors such as gender and age groups. Similarly,
signiﬁcant reduction was observed in the prevalence of subclinical
malaria in children in baseline and follow up surveys (SPR = 61%
vs. 1%, p < 0001) keeping other variables (gender and age group)
constant. (Table 3).
Effect of insecticide resistance on protective efﬁcacy of LLIN
Mean (range) mortality rate of An. culicifacies to pyrethroid in
high and low resistance clusters was 718% (530–836) and 938%
(84–100) respectively. Malaria positive cases both clinical and
subclinical were stratiﬁed based on susceptibility test data of An.
culicifacies to deltamethrin of year 2015. Clusters with high
deltamethrin resistance An. culicifacies showed almost equal
numbers of subclinical malaria cases compared to low resistance
clusters (1% vs. 14%). Overall, no interaction between the LLIN uses
and insecticide resistance of study clusters was observed (Adjusted
OR,95%CI- 0.58, 0.23-1.4; p = 0.21). (Table 4).
Impact of LLIN uses and other explanatory factors associated with
subclinical malaria
Table 5 shows results of the GEE univariate and multivariable
analysis, which demonstrated that last night use or non-use of LLIN
was one of the signiﬁcant independently associated factors
(OR = 025, 95% CI = 011, 058, p = 0001), with non-use associated
Table 1
Demographic and clinical characteristics of study population (n = 6582).
Variable Category Percent (n)
Age (in years, 2014) Mean (SD) 63 (34)
<2 73 (480)
Age group (in years, 2014) 2–4 289 (1899)
5–9 400 (2634)
10–14 Years 238 (1569)
Gender Male 493 (3246)
Insecticide resistance status (Deltamethrin 005%, 2015)
Median mortality- 84%
Low resistance clusters
(Bioassay mortality 84%)(40)
506 (3333)
High resistance clusters
(Bioassay mortality <84%) (40)
487 (3249)
Baseline 2014
(n = 6582)
Follow up 2015
(n = 5862)
Slide positivity rate Microscopy positive 74 (490) 14 (82)
Clinical malaria (with fever) Yes 14 (91) 026 (17)
Subclinical Malaria
(without fever)
Yes 61 (399) 1 (65)
Previous night fever history Yes 17 (114) 33 (196)
Loss to follow up – 109 (720/6582)
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with higher prevalence of subclinical malaria. However, malarial
infection frequency was nearly similar in both the age groups, 0–
4 and 5–14 years (09% vs. 12%, p = 0297) and between genders
(12% vs. 1%, p = 0811) with no signiﬁcant association with
subclinical malaria identiﬁed.
Discussion
Identiﬁcation and targeting of subclinical malaria cases is one of
the key challenges for countries aiming for malaria elimination.9
Children under the age of ﬁve years and between 5–14 years old are
most vulnerable to malaria infections. Malaria prevalence among
these age groups and LLIN usage the previous night are among the
few key indicators used to measure outcomes of malaria
intervention programs.21 However, asymptomatic malaria cases
have also been noted as a suitable indicator to assess the success of
programs.22 Systematic reviews have clearly suggested that LLINs,
a deﬁnitive component of malaria control programs in most
settings, if used properly, have signiﬁcant impact in reducing
malaria incidence in endemic communities.23,24 However, the
impact of LLIN use on subclinical malarial infections and residual
transmission has largely remained unknown.
The ﬁndings of the baseline survey (2014) showed that overall
prevalence of subclinical malaria infection was 61%, constituting
more than three fourths of total slide positive cases (813%) among
the enrolled children with predominance of P. falciparum infections
(676%). Studies from different parts of the world have reported
that subclinical malaria burden could be 4–5 times of total
Table 2
Host and parasite characteristics of study cohort during inclusion and follow-up.
Variable Asymptomatic Symptomatic Total malaria positive
P. falciparum P. vivax P. falciparum P. vivax
Baseline survey (n = 490 positives/6582 slides; SPR = 74%)
Number (%) 331 (676) 67 (137) 87 (178) 04 (08) 490#
Age, Mean
(years; range)
66 (1–12) 65 (1–12) 66 (1–12) 67 (4–11) 66 (1–12)
Males, n (%) 159 (480) 36 (537) 41 (471) 2 (50) 238 (486)
Asexual parasite density,
geometric mean
(per ml, range)
717 415 1680 247
(40–46760) (40–36880) (40–508880) (80–760)
Sexual parasite density,
geometric mean
(per ml, range)
99 303 157 613
(40–1720) (40–49040) (40–1440) (40–31880)
Follow up survey (n = 82 positives/5862 slides; SPR = 14%)
Number (%) 46 (561) 19 (232) 14 (171) 03 (37) 82 (100)
Age, Mean
(years; range)
7 6 7 3 7
(1–12) (1–12) (3–12) (2–4) (1–12)
Males, n (%) 21 (457) 12 (632) 05 (263) 01 (333) 39 (475)
Asexual parasite density,
geometric mean
(ml, range)
892 164 8402 1560
(40–340400) (40–1480) (80–628440) (1560)
Sexual parasite density,
geometric mean
(ml, range)
86 320 Nil 1037
(40–440) (40–8200) (360–5160)
# One case of P. Malariae was also identiﬁed and is included in the total malaria cases.
Table 3
Comparison of subclinical malaria cases in baseline and follow up survey (n = 12444).
Parameters Category Positive (%) Total (N = 12444) Unadjusted Odds ratio (95%CI) P value Adjusted OR (95%CI) P value
Survey Year 2015 65(1) 5862 0196
(018–026)
<0001 0194 (015–026) <0001
2014 399(61) 6582
Gender Male 236(37) 6111 106
(086–131)
0594 106 (085–132) 0631
Female 228(37) 6333
Age groups 5–14 years 325(38) 8479 104
(087–13)
0661 120 (098–154) 007
0–4 years 139(35) 3965
Subject level- study cluster (n = 80)
Comparison of malaria cases in baseline and follow up survey(n = 12444)
Survey Year 2015 490(74) 5862 0203 (015–027) <0001 020 (015–027) <0001
2014 82(14) 6582
Gender Male 277(45) 6111 102 (086–121) 0810 102 (085–122) 087
Female 295(47) 6333
Age groups 5–14 years 396(47) 8479 101 (086–12) 0915 12 (097–138) 011
0–4 years 176(44) 3965
Subject level- study cluster(n = 80)
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reported malaria cases,10 even in low transmission areas.25 In
India, various sporadic cross-sectional studies have suggested that
asymptomatic parasitemia prevalence could range from 29% to
84% in the transmission season.8,26–28 Thus, it can further be
speculated that a substantial proportion of subclinical malarial
infection may exist, which routinely remains undetected in the
existing surveillance system.
An active case surveillance (ACS) system to monitor the fever
cases and to ensure regular LLIN use in the selected houses showed
that LLIN use among cohort children (under 14 years old) in the
study area was 948%, which was comparatively higher than
reported in other studies.29 This higher LLIN use can be attributed
to regular fortnightly surveillance and concurrent health education
by ﬁeld staff during their visits. Another plausible explanation is
that regular visits of health workers led to positive response bias
among the respondents. However, successive attempts were made
to crosscheck the proxy indicators (hanging practices of bed nets)
as well as house-to-house health education and awareness
campaigns to improve LLIN usage30 since knowledge about malaria
transmission and educational level of head of the household is also
an important predictive factors for LLIN utilization.29
From this study, it can be stated that use of LLINs was equally
effective in protecting the cohort from clinical malaria and
subclinical malarial infections. A possible hypothesis for the
protective effect of LLIN against subclinical infection is that there
was interruption of transmission at the household level. It has been
Table 4
Malaria cases stratiﬁed according to insecticide resistance status in An. Culicifacies (n = 5862).
Last night LLIN usage vs. malaria in 2015
Insecticide resistance status Variable Category Microscopy Positive 2015 Stratiﬁed Odds ratio
(OR), 95%CI
P value Adjusted
OR
95%CI,
p value
(%) Total
Low resistance Last night LLIN use Yes 41 (14) 2840 030, 009–100 005 058
No 05 (47) 107 023–14
Total 46 (16) 2947 021
High resistance Last night LLIN use Yes 27 (1) 2718 021,
008–055
0001
No 09 (46) 197
Total 36 (123) 2915
Last night LLIN usage vs. Subclinical malaria in 2015
Subclinical malaria 2015
Low resistance Last night LLIN use Yes 33 (12%) 2840 030, 008–11 007 056
No 04 (37%) 107 021–14,
Total 37 (126%) 2947 022
High resistance Last night LLIN use Yes 21 (08%) 2718 021, 007–066 0008
No 07 (36%) 197
Total 28 (1%) 2915
Table 5
Prevalence of subclinical malaria by use of LLINs, gender, age-group and insecticide resistance status of study clusters (n = 5862).
Parameters Category Positive (%) Total
(N = 5862)
Unadjusted Odds ratio(95%CI) P value Adjusted OR
(95%CI)
P value
Last night LLIN use Yes 54(1) 5558 026
(011–060)
0002 025
(011–058)
0001
No 11(36) 304
Gender Male 33(12) 2865 108
(06–195)
0799 108
(06–194)
0811
Female 32(11) 2997
Age groups 5–14 years 46(12) 3749 140
(067–273)
0394 133
(066–265)
0297
0–4 years 19(09) 2113
Cluster resistance status High 28(1) 2915 076
(030–198)
0577 070
(027–181)
0457
Low 37(13) 2947
Subject level- study cluster (n = 80)
Overall prevalence of infection by use of LLINs, gender, age-group and insecticide resistance status of study clusters (n = 5862)
Last night LLIN use Yes 68(12) 5558 026
(012–054)
<0001 025
(012–052)
<0001
No 14(46) 304
Gender Male 39(14) 2865 095
(056–159)
0840 094
(056–159)
0825
Female 43(14) 2997
Age groups 5–14 years 64(15) 3749 132
(074–238)
0350 129
(073–229)
0382
0–4 years 18(11) 2113
Clusters resistance status High 36(12) 2915 080
(030–207)
0629 072
(028–188)
0504
Low 46(16) 2947
Subject level- study cluster (n = 80)
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observed that if malaria infection were diagnosed from a member
of one household there would be increased chance of presence of
subclinical infection in other members of the family.31 Secondly,
acquired immunity among the children as well as adults11 can also
be a plausible reason that these asymptomatic carriers can act as
source of infection at household level.
Malaria incidence and subclinical malaria prevalence were
signiﬁcantly reduced by 84% in the follow up survey relative to the
baseline, which was perhaps attributable to adequate LLIN
coverage and high usage rates by the cohort children. Nonetheless,
ACS also substantially contributed to the control of malarial
infection in the study population. A study from Kenya showed a
similar decrease in subclinical malaria due to regular ACS.32 In the
Asia Paciﬁc region, different countries have implemented variants
of active case surveillance systems to identify and reduce parasitic
carriers among reservoirs. Case detection and reactive active case
detection were among the approaches taken, although better and
more effective methods are still required.33
Parasite density, age and season are essential co-variates in
risk of developing fever.34 However, on the contrary, no major
difference in age and parasite density among subclinical and
total malaria cases was observed in the present study.
Asymptomatic parasitemia is usually higher in the dry season
as compared to the rainy season35 and the presence of
gametocyte density in the dry season probably acts as a source
of infection in the next cycle of malaria transmission.36 In the
Keshkal sub district, malaria transmission is seasonal and
malaria incidence usually peaks in the post monsoon season. It
has also been reported that increased breeding potential and
subsequently vector density during monsoon and post-monsoon
seasons directly affect the malaria transmission in low and
meso-endemic regions.29,34 In view of this, to control for this
confounding effect due to seasonal variation, both the surveys
were conducted in the same season in the consecutive years of
2014 and 2015. However, there might be a chance of year-to-
year variation due to climatic factors.
The worldwide spread of insecticide resistance among malaria
vectors has been well-established.21 It was assumed that pyre-
throid resistance can adversely affect efforts of malaria control and
elimination, though no concrete evidence is yet available although
there have been a few studies37,38 that suggest an association
between insecticide resistance and failure of malaria interven-
tions. However, under laboratory and hut trial conditions it has
been shown that LLIN remains effective despite pyrethroid
resistance in main malaria vector species.39 In India, occurrence
of pyrethroid resistance has been reported in malaria endemic
states including Chhattisgarh.20,40
Susceptibility tests carried out in 2015 have conﬁrmed
pyrethroid resistance in An. Culicifacies in most of the study
clusters (69) based on WHO cut off 98% of mortality rate.
Stratiﬁed data analysis showed that the occurrence of malaria
infection among LLIN users and non-users was similar and
resistance status was not behaving as an effect modiﬁer for LLIN
usage and malaria cases. We speculate that this could be due to
higher LLIN usage among the children and no loss of effectiveness
in LLIN efﬁcacy in protecting from malaria and subclinical malaria
was observed.
Apart from seasonal dynamics of malaria transmission, residing
in malaria hotspots at micro-geographical scale in low transmis-
sion areas is an independent predictive factor for malaria
infections.41 Cluster wise data of both the surveys identiﬁed few
independent clusters with comparatively higher number of
malaria cases, which might be due to their proximity to breeding
habitats. Such clusters may serve as a potential reservoir of
subclinical cases. Targeting these subsets of the population with
appropriate interventions could be cost-effective in clearing the
residual parasite reservoir.42,43 However, this needs to be further
corroborated by geospatial assessment, and entomological studies.
While this study has focused on the post-monsoon season,
further assessment is required during the dry season, when LLIN
utilization might reduce due to reduction in vector densities or hot
climates that deters usage. Further follow up could delineate the
effect in prevalence of subclinical malaria in the low transmission
season as well.
This study presents an ideal scenario with high LLIN use, and
well-informed household and study ﬁndings could only be
generalized to other tribal populated area within low transmission
settings, if high LLIN coverage is maintained with a robust active
surveillance activity in place.
Conclusions
There was a high proportion of subclinical malaria infections
among children in the tribal inhabited malaria endemic area of the
study, which may also be the case in areas with similar populations
and malaria transmission intensities, and therefore may inform
appropriate malaria elimination strategies. These observations
indicated that high use of LLINs can signiﬁcantly reduce the
number of subclinical malaria cases, despite vectors having
reduced susceptibility to the pyrethroid used in the LLINs.
Therefore, high LLIN coverage and usage supported by a strong
active case surveillance system would be a useful strategy in low
transmission settings where parasite reservoirs exist as subclinical
carriers.
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